Global Nilotinib Market Growth 2024-2030

March 2024 | 75 pages | ID: GD89AB27AE13EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

According to our LPI (LP Information) latest study, the global Nilotinib market size was valued at US$ 1881.2 million in 2023. With growing demand in downstream market, the Nilotinib is forecast to a readjusted size of US$ 1261.4 million by 2030 with a CAGR of -5.5% during review period.

The research report highlights the growth potential of the global Nilotinib market. Nilotinib are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Nilotinib. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Nilotinib market.

Nilotinib is a type of targeted cancer drug called a tyrosine kinase inhibitor (TKI).

Tasigna, a targeted therapy used in the treatment of certain types of leukemia, is witnessing increasing demand. Factors driving market growth include the rising incidence of leukemia, advancements in precision medicine, and the efficacy of Tasigna in treating resistant forms of the disease. Key players in the market are investing in research and development to expand the indications of Tasigna and explore its potential in combination therapies. Additionally, strategic collaborations and regulatory approvals are contributing to market expansion. However, challenges such as high treatment costs and the availability of generic alternatives may impact market growth.

Key Features:

The report on Nilotinib market reflects various aspects and provide valuable insights into the industry.

Market Size and Growth: The research report provide an overview of the current size and growth of the Nilotinib market. It may include historical data, market segmentation by Type (e.g., 50mg, 200mg), and regional breakdowns.

Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Nilotinib market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.

Competitive Landscape: The research report provides analysis of the competitive landscape within the Nilotinib market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.

Technological Developments: The research report can delve into the latest technological developments in the Nilotinib industry. This include advancements in Nilotinib technology, Nilotinib new entrants, Nilotinib new investment, and other innovations that are shaping the future of Nilotinib.

Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Nilotinib market. It includes factors influencing customer ' purchasing decisions, preferences for Nilotinib product.

Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Nilotinib market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Nilotinib market. The report also evaluates the effectiveness of these policies in driving market growth.

Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Nilotinib market.

Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Nilotinib industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.

Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Nilotinib market.

Market Segmentation:

Nilotinib market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Segmentation by type

• 50mg
• 200mg
• Other

Segmentation by application

• Hospital
• Drugs Store
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Novartis

Key Questions Addressed in this Report

What is the 10-year outlook for the global Nilotinib market?

What factors are driving Nilotinib market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Nilotinib market opportunities vary by end market size?

How does Nilotinib break out type, application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Nilotinib Annual Sales 2019-2030
  2.1.2 World Current & Future Analysis for Nilotinib by Geographic Region, 2019, 2023 & 2030
  2.1.3 World Current & Future Analysis for Nilotinib by Country/Region, 2019, 2023 & 2030
2.2 Nilotinib Segment by Type
  2.2.1 50mg
  2.2.2 200mg
  2.2.3 Other
2.3 Nilotinib Sales by Type
  2.3.1 Global Nilotinib Sales Market Share by Type (2019-2024)
  2.3.2 Global Nilotinib Revenue and Market Share by Type (2019-2024)
  2.3.3 Global Nilotinib Sale Price by Type (2019-2024)
2.4 Nilotinib Segment by Application
  2.4.1 Hospital
  2.4.2 Drugs Store
  2.4.3 Other
2.5 Nilotinib Sales by Application
  2.5.1 Global Nilotinib Sale Market Share by Application (2019-2024)
  2.5.2 Global Nilotinib Revenue and Market Share by Application (2019-2024)
  2.5.3 Global Nilotinib Sale Price by Application (2019-2024)

3 GLOBAL NILOTINIB BY COMPANY

3.1 Global Nilotinib Breakdown Data by Company
  3.1.1 Global Nilotinib Annual Sales by Company (2019-2024)
  3.1.2 Global Nilotinib Sales Market Share by Company (2019-2024)
3.2 Global Nilotinib Annual Revenue by Company (2019-2024)
  3.2.1 Global Nilotinib Revenue by Company (2019-2024)
  3.2.2 Global Nilotinib Revenue Market Share by Company (2019-2024)
3.3 Global Nilotinib Sale Price by Company
3.4 Key Manufacturers Nilotinib Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Nilotinib Product Location Distribution
  3.4.2 Players Nilotinib Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR NILOTINIB BY GEOGRAPHIC REGION

4.1 World Historic Nilotinib Market Size by Geographic Region (2019-2024)
  4.1.1 Global Nilotinib Annual Sales by Geographic Region (2019-2024)
  4.1.2 Global Nilotinib Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Nilotinib Market Size by Country/Region (2019-2024)
  4.2.1 Global Nilotinib Annual Sales by Country/Region (2019-2024)
  4.2.2 Global Nilotinib Annual Revenue by Country/Region (2019-2024)
4.3 Americas Nilotinib Sales Growth
4.4 APAC Nilotinib Sales Growth
4.5 Europe Nilotinib Sales Growth
4.6 Middle East & Africa Nilotinib Sales Growth

5 AMERICAS

5.1 Americas Nilotinib Sales by Country
  5.1.1 Americas Nilotinib Sales by Country (2019-2024)
  5.1.2 Americas Nilotinib Revenue by Country (2019-2024)
5.2 Americas Nilotinib Sales by Type
5.3 Americas Nilotinib Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Nilotinib Sales by Region
  6.1.1 APAC Nilotinib Sales by Region (2019-2024)
  6.1.2 APAC Nilotinib Revenue by Region (2019-2024)
6.2 APAC Nilotinib Sales by Type
6.3 APAC Nilotinib Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Nilotinib by Country
  7.1.1 Europe Nilotinib Sales by Country (2019-2024)
  7.1.2 Europe Nilotinib Revenue by Country (2019-2024)
7.2 Europe Nilotinib Sales by Type
7.3 Europe Nilotinib Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Nilotinib by Country
  8.1.1 Middle East & Africa Nilotinib Sales by Country (2019-2024)
  8.1.2 Middle East & Africa Nilotinib Revenue by Country (2019-2024)
8.2 Middle East & Africa Nilotinib Sales by Type
8.3 Middle East & Africa Nilotinib Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Nilotinib
10.3 Manufacturing Process Analysis of Nilotinib
10.4 Industry Chain Structure of Nilotinib

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Nilotinib Distributors
11.3 Nilotinib Customer

12 WORLD FORECAST REVIEW FOR NILOTINIB BY GEOGRAPHIC REGION

12.1 Global Nilotinib Market Size Forecast by Region
  12.1.1 Global Nilotinib Forecast by Region (2025-2030)
  12.1.2 Global Nilotinib Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Nilotinib Forecast by Type
12.7 Global Nilotinib Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 Novartis
  13.1.1 Novartis Company Information
  13.1.2 Novartis Nilotinib Product Portfolios and Specifications
  13.1.3 Novartis Nilotinib Sales, Revenue, Price and Gross Margin (2019-2024)
  13.1.4 Novartis Main Business Overview
  13.1.5 Novartis Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Nilotinib Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Nilotinib Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of 50mg
Table 4. Major Players of 200mg
Table 5. Major Players of Other
Table 6. Global Nilotinib Sales by Type (2019-2024) & (K Units)
Table 7. Global Nilotinib Sales Market Share by Type (2019-2024)
Table 8. Global Nilotinib Revenue by Type (2019-2024) & ($ million)
Table 9. Global Nilotinib Revenue Market Share by Type (2019-2024)
Table 10. Global Nilotinib Sale Price by Type (2019-2024) & (USD/Unit)
Table 11. Global Nilotinib Sales by Application (2019-2024) & (K Units)
Table 12. Global Nilotinib Sales Market Share by Application (2019-2024)
Table 13. Global Nilotinib Revenue by Application (2019-2024)
Table 14. Global Nilotinib Revenue Market Share by Application (2019-2024)
Table 15. Global Nilotinib Sale Price by Application (2019-2024) & (USD/Unit)
Table 16. Global Nilotinib Sales by Company (2019-2024) & (K Units)
Table 17. Global Nilotinib Sales Market Share by Company (2019-2024)
Table 18. Global Nilotinib Revenue by Company (2019-2024) ($ Millions)
Table 19. Global Nilotinib Revenue Market Share by Company (2019-2024)
Table 20. Global Nilotinib Sale Price by Company (2019-2024) & (USD/Unit)
Table 21. Key Manufacturers Nilotinib Producing Area Distribution and Sales Area
Table 22. Players Nilotinib Products Offered
Table 23. Nilotinib Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Nilotinib Sales by Geographic Region (2019-2024) & (K Units)
Table 27. Global Nilotinib Sales Market Share Geographic Region (2019-2024)
Table 28. Global Nilotinib Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global Nilotinib Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global Nilotinib Sales by Country/Region (2019-2024) & (K Units)
Table 31. Global Nilotinib Sales Market Share by Country/Region (2019-2024)
Table 32. Global Nilotinib Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global Nilotinib Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas Nilotinib Sales by Country (2019-2024) & (K Units)
Table 35. Americas Nilotinib Sales Market Share by Country (2019-2024)
Table 36. Americas Nilotinib Revenue by Country (2019-2024) & ($ Millions)
Table 37. Americas Nilotinib Revenue Market Share by Country (2019-2024)
Table 38. Americas Nilotinib Sales by Type (2019-2024) & (K Units)
Table 39. Americas Nilotinib Sales by Application (2019-2024) & (K Units)
Table 40. APAC Nilotinib Sales by Region (2019-2024) & (K Units)
Table 41. APAC Nilotinib Sales Market Share by Region (2019-2024)
Table 42. APAC Nilotinib Revenue by Region (2019-2024) & ($ Millions)
Table 43. APAC Nilotinib Revenue Market Share by Region (2019-2024)
Table 44. APAC Nilotinib Sales by Type (2019-2024) & (K Units)
Table 45. APAC Nilotinib Sales by Application (2019-2024) & (K Units)
Table 46. Europe Nilotinib Sales by Country (2019-2024) & (K Units)
Table 47. Europe Nilotinib Sales Market Share by Country (2019-2024)
Table 48. Europe Nilotinib Revenue by Country (2019-2024) & ($ Millions)
Table 49. Europe Nilotinib Revenue Market Share by Country (2019-2024)
Table 50. Europe Nilotinib Sales by Type (2019-2024) & (K Units)
Table 51. Europe Nilotinib Sales by Application (2019-2024) & (K Units)
Table 52. Middle East & Africa Nilotinib Sales by Country (2019-2024) & (K Units)
Table 53. Middle East & Africa Nilotinib Sales Market Share by Country (2019-2024)
Table 54. Middle East & Africa Nilotinib Revenue by Country (2019-2024) & ($ Millions)
Table 55. Middle East & Africa Nilotinib Revenue Market Share by Country (2019-2024)
Table 56. Middle East & Africa Nilotinib Sales by Type (2019-2024) & (K Units)
Table 57. Middle East & Africa Nilotinib Sales by Application (2019-2024) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Nilotinib
Table 59. Key Market Challenges & Risks of Nilotinib
Table 60. Key Industry Trends of Nilotinib
Table 61. Nilotinib Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Nilotinib Distributors List
Table 64. Nilotinib Customer List
Table 65. Global Nilotinib Sales Forecast by Region (2025-2030) & (K Units)
Table 66. Global Nilotinib Revenue Forecast by Region (2025-2030) & ($ millions)
Table 67. Americas Nilotinib Sales Forecast by Country (2025-2030) & (K Units)
Table 68. Americas Nilotinib Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. APAC Nilotinib Sales Forecast by Region (2025-2030) & (K Units)
Table 70. APAC Nilotinib Revenue Forecast by Region (2025-2030) & ($ millions)
Table 71. Europe Nilotinib Sales Forecast by Country (2025-2030) & (K Units)
Table 72. Europe Nilotinib Revenue Forecast by Country (2025-2030) & ($ millions)
Table 73. Middle East & Africa Nilotinib Sales Forecast by Country (2025-2030) & (K Units)
Table 74. Middle East & Africa Nilotinib Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Global Nilotinib Sales Forecast by Type (2025-2030) & (K Units)
Table 76. Global Nilotinib Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 77. Global Nilotinib Sales Forecast by Application (2025-2030) & (K Units)
Table 78. Global Nilotinib Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 79. Novartis Basic Information, Nilotinib Manufacturing Base, Sales Area and Its Competitors
Table 80. Novartis Nilotinib Product Portfolios and Specifications
Table 81. Novartis Nilotinib Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 82. Novartis Main Business
Table 83. Novartis Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Nilotinib
Figure 2. Nilotinib Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Nilotinib Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Nilotinib Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Nilotinib Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of 50mg
Figure 10. Product Picture of 200mg
Figure 11. Product Picture of Other
Figure 12. Global Nilotinib Sales Market Share by Type in 2023
Figure 13. Global Nilotinib Revenue Market Share by Type (2019-2024)
Figure 14. Nilotinib Consumed in Hospital
Figure 15. Global Nilotinib Market: Hospital (2019-2024) & (K Units)
Figure 16. Nilotinib Consumed in Drugs Store
Figure 17. Global Nilotinib Market: Drugs Store (2019-2024) & (K Units)
Figure 18. Nilotinib Consumed in Other
Figure 19. Global Nilotinib Market: Other (2019-2024) & (K Units)
Figure 20. Global Nilotinib Sales Market Share by Application (2023)
Figure 21. Global Nilotinib Revenue Market Share by Application in 2023
Figure 22. Nilotinib Sales Market by Company in 2023 (K Units)
Figure 23. Global Nilotinib Sales Market Share by Company in 2023
Figure 24. Nilotinib Revenue Market by Company in 2023 ($ Million)
Figure 25. Global Nilotinib Revenue Market Share by Company in 2023
Figure 26. Global Nilotinib Sales Market Share by Geographic Region (2019-2024)
Figure 27. Global Nilotinib Revenue Market Share by Geographic Region in 2023
Figure 28. Americas Nilotinib Sales 2019-2024 (K Units)
Figure 29. Americas Nilotinib Revenue 2019-2024 ($ Millions)
Figure 30. APAC Nilotinib Sales 2019-2024 (K Units)
Figure 31. APAC Nilotinib Revenue 2019-2024 ($ Millions)
Figure 32. Europe Nilotinib Sales 2019-2024 (K Units)
Figure 33. Europe Nilotinib Revenue 2019-2024 ($ Millions)
Figure 34. Middle East & Africa Nilotinib Sales 2019-2024 (K Units)
Figure 35. Middle East & Africa Nilotinib Revenue 2019-2024 ($ Millions)
Figure 36. Americas Nilotinib Sales Market Share by Country in 2023
Figure 37. Americas Nilotinib Revenue Market Share by Country in 2023
Figure 38. Americas Nilotinib Sales Market Share by Type (2019-2024)
Figure 39. Americas Nilotinib Sales Market Share by Application (2019-2024)
Figure 40. United States Nilotinib Revenue Growth 2019-2024 ($ Millions)
Figure 41. Canada Nilotinib Revenue Growth 2019-2024 ($ Millions)
Figure 42. Mexico Nilotinib Revenue Growth 2019-2024 ($ Millions)
Figure 43. Brazil Nilotinib Revenue Growth 2019-2024 ($ Millions)
Figure 44. APAC Nilotinib Sales Market Share by Region in 2023
Figure 45. APAC Nilotinib Revenue Market Share by Regions in 2023
Figure 46. APAC Nilotinib Sales Market Share by Type (2019-2024)
Figure 47. APAC Nilotinib Sales Market Share by Application (2019-2024)
Figure 48. China Nilotinib Revenue Growth 2019-2024 ($ Millions)
Figure 49. Japan Nilotinib Revenue Growth 2019-2024 ($ Millions)
Figure 50. South Korea Nilotinib Revenue Growth 2019-2024 ($ Millions)
Figure 51. Southeast Asia Nilotinib Revenue Growth 2019-2024 ($ Millions)
Figure 52. India Nilotinib Revenue Growth 2019-2024 ($ Millions)
Figure 53. Australia Nilotinib Revenue Growth 2019-2024 ($ Millions)
Figure 54. China Taiwan Nilotinib Revenue Growth 2019-2024 ($ Millions)
Figure 55. Europe Nilotinib Sales Market Share by Country in 2023
Figure 56. Europe Nilotinib Revenue Market Share by Country in 2023
Figure 57. Europe Nilotinib Sales Market Share by Type (2019-2024)
Figure 58. Europe Nilotinib Sales Market Share by Application (2019-2024)
Figure 59. Germany Nilotinib Revenue Growth 2019-2024 ($ Millions)
Figure 60. France Nilotinib Revenue Growth 2019-2024 ($ Millions)
Figure 61. UK Nilotinib Revenue Growth 2019-2024 ($ Millions)
Figure 62. Italy Nilotinib Revenue Growth 2019-2024 ($ Millions)
Figure 63. Russia Nilotinib Revenue Growth 2019-2024 ($ Millions)
Figure 64. Middle East & Africa Nilotinib Sales Market Share by Country in 2023
Figure 65. Middle East & Africa Nilotinib Revenue Market Share by Country in 2023
Figure 66. Middle East & Africa Nilotinib Sales Market Share by Type (2019-2024)
Figure 67. Middle East & Africa Nilotinib Sales Market Share by Application (2019-2024)
Figure 68. Egypt Nilotinib Revenue Growth 2019-2024 ($ Millions)
Figure 69. South Africa Nilotinib Revenue Growth 2019-2024 ($ Millions)
Figure 70. Israel Nilotinib Revenue Growth 2019-2024 ($ Millions)
Figure 71. Turkey Nilotinib Revenue Growth 2019-2024 ($ Millions)
Figure 72. GCC Country Nilotinib Revenue Growth 2019-2024 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Nilotinib in 2023
Figure 74. Manufacturing Process Analysis of Nilotinib
Figure 75. Industry Chain Structure of Nilotinib
Figure 76. Channels of Distribution
Figure 77. Global Nilotinib Sales Market Forecast by Region (2025-2030)
Figure 78. Global Nilotinib Revenue Market Share Forecast by Region (2025-2030)
Figure 79. Global Nilotinib Sales Market Share Forecast by Type (2025-2030)
Figure 80. Global Nilotinib Revenue Market Share Forecast by Type (2025-2030)
Figure 81. Global Nilotinib Sales Market Share Forecast by Application (2025-2030)
Figure 82. Global Nilotinib Revenue Market Share Forecast by Application (2025-2030)